Cargando…

Assessment of SARS-CoV-2 infectivity of upper respiratory specimens from COVID-19 patients by virus isolation using VeroE6/TMPRSS2 cells

BACKGROUND: An outbreak of novel coronavirus (SARS-CoV-2)-associated respiratory infectious diseases (COVID-19) emerged in 2019 and has spread rapidly in humans around the world. The demonstration of in vitro infectiousness of respiratory specimens is an informative surrogate for SARS-CoV-2 transmis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yamada, Souichi, Fukushi, Shuetsu, Kinoshita, Hitomi, Ohnishi, Makoto, Suzuki, Tadaki, Fujimoto, Tsuguto, Saijo, Masayuki, Maeda, Ken
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Respiratory Infection
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907832/ https://www.ncbi.nlm.nih.gov/pubmed/33627333 http://dx.doi.org/10.1136/bmjresp-2020-000830

Ejemplares similares

Characterization of Persistent SARS-CoV Infection in Vero E6 Cells
por: Mizutani, Tetsuya, et al.
Publicado: (2006)

Importance of Akt signaling pathway for apoptosis in SARS-CoV-infected Vero E6 cells
por: Mizutani, Tetsuya, et al.
Publicado: (2004)

Regulation of p90RSK phosphorylation by SARS‐CoV infection in Vero E6 cells
por: Mizutani, Tetsuya, et al.
Publicado: (2006)

Tyrosine dephosphorylation of STAT3 in SARS coronavirus‐infected Vero E6 cells
por: Mizutani, Tetsuya, et al.
Publicado: (2004)

JNK and PI3k/Akt signaling pathways are required for establishing persistent SARS-CoV infection in Vero E6 cells
por: Mizutani, Tetsuya, et al.
Publicado: (2005)

Higher SARS-CoV-2 detection of oropharyngeal compared with nasopharyngeal or saliva specimen for molecular testing: a multicentre randomised comparative accuracy study
por: Todsen, Tobias, et al.
Publicado: (2023)

Perceptions of medical students towards antibiotic prescribing for upper respiratory tract infections in Saudi Arabia
por: Harakeh, Steve, et al.
Publicado: (2015)

Essential role of TMPRSS2 in SARS-CoV-2 infection in murine airways
por: Iwata-Yoshikawa, Naoko, et al.
Publicado: (2022)

Coronary artery calcium score may be a novel predictor of COVID-19 prognosis: a retrospective study
por: Takeshita, Yuichiro, et al.
Publicado: (2021)

Characteristics and outcomes of admitted patients infected with SARS-CoV-2 in Uganda
por: Kirenga, Bruce, et al.
Publicado: (2020)

Prevalence and significance of pulmonary disease on lung ultrasonography in outpatients with SARS-CoV-2 infection
por: Fairchild, Robert M, et al.
Publicado: (2021)

Lung directed antibody gene transfer confers protection against SARS-CoV-2 infection
por: Du, Yue, et al.
Publicado: (2022)

SARS-CoV-2 seroprevalence and asymptomatic viral carriage in healthcare workers: a cross-sectional study
por: Shields, Adrian, et al.
Publicado: (2020)

Vitamin D status: a U-shaped relationship for SARS-CoV-2 seropositivity in UK healthcare workers
por: Lugg, Sebastian T, et al.
Publicado: (2022)

High prevalence of multiple serotypes of pneumococci in patients with pneumonia and their associated risk factors
por: Dhoubhadel, Bhim Gopal, et al.
Publicado: (2022)

Repurposed drug studies on the primary prevention of SARS-CoV-2 infection during the pandemic: systematic review and meta-analysis
por: Zhou, Guiling, et al.
Publicado: (2023)

Cross-sectional study evaluating the impact of SARS-CoV-2 variants on Long COVID outcomes in UK hospital survivors
por: Saigal, Anita, et al.
Publicado: (2023)

Utility of established prognostic scores in COVID-19 hospital admissions: multicentre prospective evaluation of CURB-65, NEWS2 and qSOFA
por: Bradley, Patrick, et al.
Publicado: (2020)

Serological responses to SARS-CoV-2 following non-hospitalised infection: clinical and ethnodemographic features associated with the magnitude of the antibody response
por: Shields, Adrian M, et al.
Publicado: (2021)

Evaluation of the Post-COVID-19 Functional Status (PCFS) Scale in a cohort of patients recovering from hypoxemic SARS-CoV-2 pneumonia
por: Benkalfate, Naïla, et al.
Publicado: (2022)

SARS-CoV-2 lineage B.1.1.7 is associated with greater disease severity among hospitalised women but not men: multicentre cohort study
por: Stirrup, Oliver, et al.
Publicado: (2021)

Clinical phenotypes and outcomes of SARS-CoV-2, influenza, RSV and seven other respiratory viruses: a retrospective study using complete hospital data
por: Hedberg, Pontus, et al.
Publicado: (2022)

Antibody responses and risk factors associated with impaired immunological outcomes following two doses of BNT162b2 COVID-19 vaccination in patients with chronic pulmonary diseases
por: Harboe, Zitta Barrella, et al.
Publicado: (2022)

Placental mesenchymal stem cells boost M2 alveolar over M1 bone marrow macrophages via IL-1β in Klebsiella-mediated acute respiratory distress syndrome
por: Wang, Li-Tzu, et al.
Publicado: (2023)

Development of an RT-LAMP Assay for the Rapid Detection of SFTS Virus
por: Sano, Shiori, et al.
Publicado: (2021)

Systematic Exploration of SARS-CoV-2 Adaptation to Vero E6, Vero E6/TMPRSS2, and Calu-3 Cells
por: Aiewsakun, Pakorn, et al.
Publicado: (2023)

Comprehensive and long-term surveys of COVID-19 sequelae in Japan, an ambidirectional multicentre cohort study: study protocol
por: Nakagawara, Kensuke, et al.
Publicado: (2021)

High prevalence of subclinical tuberculosis in HIV-1-infected persons without advanced immunodeficiency: implications for TB screening
por: Oni, Tolu, et al.
Publicado: (2011)

Diagnostic importance of pulmonary interleukin-1β and interleukin-8 in ventilator-associated pneumonia
por: Conway Morris, Andrew, et al.
Publicado: (2010)

Healthy but not RSV-infected lung epithelial cells profoundly inhibit T cell activation
por: Wang, H, et al.
Publicado: (2009)

Paracetamol reduces influenza-induced immunopathology in a mouse model of infection without compromising virus clearance or the generation of protective immunity
por: Lauder, Sarah N, et al.
Publicado: (2011)

Bronchoalveolar CD4(+) T cell responses to respiratory antigens are impaired in HIV-infected adults
por: Jambo, Kondwani C, et al.
Publicado: (2011)

Clinical and laboratory features distinguishing pandemic H1N1 influenza-related pneumonia from interpandemic community-acquired pneumonia in adults
por: Bewick, Thomas, et al.
Publicado: (2011)

Risk factors for hospitalisation and poor outcome with pandemic A/H1N1 influenza: United Kingdom first wave (May–September 2009)
por: Nguyen-Van-Tam, J S, et al.
Publicado: (2010)

New perspectives on community-acquired pneumonia in 388 406 patients. Results from a nationwide mandatory performance measurement programme in healthcare quality
por: Ewig, S, et al.
Publicado: (2009)

Predictors of clinical outcome in a national hospitalised cohort across both waves of the influenza A/H1N1 pandemic 2009–2010 in the UK
por: Myles, Puja R, et al.
Publicado: (2012)

Viral and host factors determine innate immune responses in airway epithelial cells from children with wheeze and atopy
por: Spann, Kirsten M, et al.
Publicado: (2014)

Differential response to bacteria, and TOLLIP expression, in the human respiratory tract
por: Moncayo-Nieto, Olga Lucia, et al.
Publicado: (2014)

Prevalence and risk factors for chronic co-infection in pulmonary Mycobacterium avium complex disease
por: Fujita, Kohei, et al.
Publicado: (2014)

Improvement of CRB-65 as a prognostic tool in adult patients with community-acquired pneumonia
por: Dwyer, Richard, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_6m4ea2p43nsineul076a042kjg